Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€87.00

€87.00

0.580%
0.5
0.580%
€97.00
 
24.04.24 / Frankfurt WKN: A0YBKM / Symbol: ADUS / Name: Addus Homecare / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Addus Homecare Corp. Stock

The Addus Homecare Corp. stock is trending slightly upwards today, with an increase of €0.50 (0.580%) compared to yesterday's price.
With 12 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 97 € there is a slightly positive potential of 11.49% for Addus Homecare Corp. compared to the current price of 87.0 €.
So far the community has only identified positive things for Addus Homecare Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Addus Homecare Corp. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Addus Homecare Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Addus Homecare Corp. 0.580% -3.889% -5.978% -13.500% 2.976% -5.464% 52.504%
Surgery Partners Inc 0.850% 2.609% -7.087% -34.078% -18.056% -39.796% 141.333%
Capital Senior Living Corp. - 10.606% 8.148% 317.143% 237.572% -11.515% -45.685%
Healthstream Inc. 9.010% -2.632% -7.500% -9.756% -7.500% 20.000% -2.738%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-29

Addus Homecare (ADUS) is a reputable company in the Healthcare Providers & Services industry. At first glance, the financials of ADUS seem to present a stable and growing company with substantial assets and revenue. However, a thorough analysis of the financial statements reveals prominent pros and cons that a discerning investor should consider.

Growing Revenue: The total revenue of ADUS has shown a consistent growth over the past three years, increasing from $764.775 million in 2020 to $864.499 million in 2021, and further to $951.120 million in 2022. Revenue growth is an essential indicator of a company's success and expansion in its market.

Solid Gross Profit: ADUS has maintained a healthy gross profit throughout the analyzed years, with the figures reading $226.237 million in 2020, $269.848 million in 2021, and $299.739 million in 2022. These figures indicate that the company has been effectively managing its cost of operations and generating solid returns on its sales.

Comments

Prediction Sell
Perf. (%) 1.74%
Target price 77.763
Change
Ends at 23.04.25

Addus HomeCare Co. (NASDAQ: ADUS) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $83.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -6.45%
Target price 108.784
Change
Ends at 26.03.25

Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $118.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 3.57%
Target price 94.452
Change
Ends at 28.02.25

Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $102.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Show more